Could postinterferon treatment α‐fetoprotein levels truly predict hepatocarcinogenesis?
Gin‐Ho Lo – 12 February 2014
Blockade of CD47‐mediated cathepsin S/protease‐activated receptor 2 signaling provides a therapeutic target for hepatocellular carcinoma
Terence Kin‐Wah Lee, Vincent Chi‐Ho Cheung, Ping Lu, Eunice Yuen Ting Lau, Stephanie Ma, Kwan Ho Tang, Man Tong, Jessica Lo, Irene Oi Lin Ng – 12 February 2014 – Identification of therapeutic targets against tumor‐initiating cells (TICs) is a priority in the development of new therapeutic paradigms against cancer. We enriched a TIC population capable of tumor initiation and self‐renewal by serial passages of hepatospheres with chemotherapeutic agents. In chemoresistant hepatospheres, CD47 was found to be up‐regulated, when compared with differentiated progenies.
Postinterferon α‐fetoprotein elevation and risk of hepatocellular carcinoma development after sustained virological response: Cause or results?
Hidenori Toyoda, Takashi Kumada, Toshifumi Tada – 12 February 2014
Reply
Yasuhiro Asahina, Kaoru Tsuchiya, Namiki Izumi – 12 February 2014
Treatment of autoimmune hepatitis
Michael P. Manns, Richard Taubert – 10 February 2014 – Watch a video presentation of this article
Overlap syndromes
Albert J. Czaja – 10 February 2014 – Watch a video presentation of this article
Changing epidemiology and natural history of primary biliary cirrhosis
Meredith Borman, Mark G. Swain – 10 February 2014 – Watch a video presentation of this article
Autoimmune hepatitis in childhood
Giorgina Mieli‐Vergani, Diego Vergani – 10 February 2014 – Watch a video presentation of this article
Clinical presentation and natural history of autoimmune hepatitis
Michael R. Lucey, John M. Vierling – 10 February 2014 – Watch a video presentation of this article